Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

2020 Virtual ESMO Review
L

2020 ESMO Update on mPDAC: Does the Addition of Dual Immune Checkpoint Inhibitors to Gem and Nab-p Result in Improved OS, PFS, or ORR?

By 2020 Virtual ESMO Review FEATURING Louise Connell
By 2020 Virtual ESMO Review FEATURING Louise Connell
229 views
November 4, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Featured Video

18:30
Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley
Gastrointestinal
13:14

Organ Preservation in Rectal Cancer: Neoadjuvant Short-Course RT vs.…

Memorial Sloan Kettering Cancer Center

P. Romesser

76 views
13:50

ESMO 2024 Insights: DESTINY-Gastric03 - T-DXd Monotherapy and Combin…

2024 ESMO Annual Meeting Insights Hub

Y. Janjigian

125 views
04:39

ASCO® GI 2024 Insights: "PROOF 301 Trial - Oral FGFR Inhibitor Infig…

Insights from 2024 ASCO® GI Annual Meeting

G. Abou-Alfa

172 views
06:31

CheckMate 649 Trial Biomarker Analyses of Nivo + Ipi vs. Chemo for P…

ecancer

Y. Y. Janjigian

231 views
31:25

Updates in Rectal Cancer: Optimizing Response, Preserving the Organ,…

Total Health

J. Smith

1.2K views
10:36

Pathophysiologic Foundations in HCC/BTC: Immune System as a Therapeu…

CE Concepts

J. Harding

78 views
11:02

ASCO GI 2023 3-Year Follow-Up From CheckMate 649: Nivo + Chemo vs. C…

ASCO GI 2023 Conference Coverage

Y. Y. Janjigian

598 views
07:43

ASCO GI 2023 ctDNA for Response Assessment in Patients With Anal Can…

ASCO GI 2023 Conference Coverage

J. Alvarez

130 views
06:16

ASCO GI 2023 on Organ Preservation and Total Neoadjuvant Therapy for…

ASCO GI 2023 Conference Coverage

P. Romesser

360 views
38:04

Advances in IO and Targeted Agents in Gastroesophageal Cancer

Debbie's Dream Foundation

D. Ilson

616 views
05:41

An Overview of Treatment Advances in Gastric Cancer

ecancer

D. Ilson

327 views
04:07

ASCO 2022: Single-Agent PD-1 Blockade as Curative-Intent Treatment i…

ecancer

A. Cercek

64 views
09:42

ASCO 2022 Targeting HER2 Mutation-Positive Advanced Biliary Tract Ca…

ASCO 2022 Conference Coverage

J. Harding

91 views
58

Lecture Summary - ASCO 2022 Targeting HER2 Mutation-Positive Advance…

ASCO 2022 Conference Coverage

J. Harding

16 views
06:42

ASCO 2022 on PROOF 301 Trial: Updates on Infigratinib vs. Gemcitabin…

ASCO 2022 Conference Coverage

G. Abou-Alfa

1.1K views
23

Lecture Summary - ASCO 2022 Updates on Infigratinib vs. Gemcitabine …

ASCO 2022 Conference Coverage

G. Abou-Alfa

104 views
07:48

Tremelimumab and Durvalumab as 1L in Unresectable HCC: Phase 3 HIMAL…

ecancer

G. Abou-Alfa

257 views
20:26

Incidental Findings From Somatic Testing and Implications for Heredi…

Collaborative Group of the Americas for Inherited Gastrointestinal Cancers

Z. Stadler

145 views
08:15

ASCO GI 2022 on a Quality-Adjusted Time Without Symptoms or Toxicity…

ASCO GI 2022 Conference Coverage

R. Sugarman

433 views
05:49

ASCO GI 2022 Updates on the Dose-Escalation & Dose-Expansion Study o…

ASCO GI 2022 Conference Coverage

Y. Y. Janjigian

230 views
09:30

ESMO 2021 Update on Nivo + Chemo or Ipi vs. Chemo as 1L Treatment in…

Memorial Sloan Kettering Cancer Center

Y. Y. Janjigian

212 views
07:44

ESMO 2021 Abstract Review on Genomic Landscape of Late-Stage Gastric…

Memorial Sloan Kettering Cancer Center

Y. Y. Janjigian

204 views
16:43

Gastric Cancer: Advances in Systemic Therapy

Debbie's Dream Foundation

D. Ilson

117 views
07:10

2021 ASCO CRC Updates: 1L Pembro vs. Chemo, Maintenance Chemo, 2L an…

2021 ASCO Virtual Direct™ Highlights

L. Connell

64 views
09:50

1L Treatment Updates for Advanced GE/GEJ Cancers: OS Data for Nivo+I…

Memorial Sloan Kettering Cancer Center

Y. Janjigian

36 views
21:21

Frontline Management of Advanced GEJ Cancers: Will 5FU/Oxaliplatin +…

Memorial Sloan Kettering Cancer Center

Y. Y. Janjigian

414 views
11:00

BRAF Alterations in Advanced CRC: How Common Are V600E Mutations? Ho…

Memorial Sloan Kettering Cancer Center

R. Yaeger

175 views
17:05

Liver-Directed Therapy for mCRC: What Is the Goal, When to Use and H…

Memorial Sloan Kettering Cancer Center

A. Cercek

207 views
13:27

2020 ESMO Update on mPDAC: Does the Addition of Dual Immune Checkpoi…

2020 Virtual ESMO Review

L. Connell

229 views
08:07

2020 ESMO Update on Metastatic Pancreatic Cancer: What Does the Qoli…

2020 Virtual ESMO Review

L. Connell

64 views
11:33

2020 ASCO Update on Locoregional CRC: 3 vs. 6 Months of Adjuvant Oxa…

2020 ASCO Virtual Direct™ Highlights

L. Connell

395 views
09:21

2020 ASCO Update on Advanced CRC: Should Pembrolizumab Be The New So…

2020 ASCO Virtual Direct™ Highlights

L. Connell

499 views
14:43

2020 ASCO Update on Advanced CRC: Is Recently FDA Approved Encorafen…

2020 ASCO Virtual Direct™ Highlights

L. Connell

190 views
22:02

The Role of Modern RT Techniques in Management of Esophagogastric Ca…

Memorial Sloan Kettering Cancer Center

A. Wu

100 views
18:32

Advanced Surgical Techniques for Early Stage Esophagogastric Cancer:…

Memorial Sloan Kettering Cancer Center

D. Molena

32 views
20:17

Current and Future Personalized Systemic Targets in Esophagogastric …

Memorial Sloan Kettering Cancer Center

G. Ku

288 views